🇺🇸 FDA
Pipeline program

VGX-3100

HPV-002

Phase 1 mab completed

Quick answer

VGX-3100 for Human Papillomavirus (HPV) is a Phase 1 program (mab) at INOVIO PHARMACEUTICALS, INC. with 1 ClinicalTrials.gov record(s).

Program details

Company
INOVIO PHARMACEUTICALS, INC.
Indication
Human Papillomavirus (HPV)
Phase
Phase 1
Modality
mab
Status
completed

Clinical trials